AGP Executive Report
Last update: 11 hours agoMedical Devices: China has approved a brain implant designed to help people with paralysis regain hand function, marking a notable step in assistive technology. Cancer Research: Chinese-developed cancer drugs drew a strong showing at the ESMO congress: 29 studies were selected as late-breaking abstracts, including five for presidential sessions. A China trial also found savolitinib plus Tagrisso extended median survival by about five months over chemotherapy in MET-driven lung cancer. Rare-Disease Care: China and Indonesia are deepening health cooperation, with efforts aimed at improving care for patients with rare diseases. Aging and Care: China’s older population now exceeds its child population, adding urgency to community-based eldercare, which the country is expanding. Heart Health: A study of nearly 486,000 adults linked regular tea drinking with an 11% lower risk of heart and vascular disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
